CannabisNewsWire
Editorial Coverage: The growing popularity of cannabidiol
(CBD), a powerful but nonpsychoactive cannabinoid found in plants
of the cannabis family such as industrial hemp, has a lot to do
with consumer experience roundly validating the increasingly body
of scientific evidence for CBD’s therapeutic value.
- CBD demand is increasing rapidly as consumers run ahead of the
studies.
- Branding is key to capturing market share while formulation
quality drives consumer loyalty.
- The global potential for the CBD market is immense and largely
untapped.
Marijuana Company of America Inc. (OTC: MCOA) (MCOA
Profile) has taken several key steps to set itself up
as a power player in the burgeoning CBD space, acting as a
cultivation site landlord while also developing revolutionary
products containing proprietary CBD compounds via its wholly owned
subsidiary, hempSMART.
CV Sciences Inc. (OTCQB: CVSI) just introduced
PlusCBD Oil™ Gummies at the Natural Product
Expo East 2018. Los Angeles-based MedMen (CSE: MMEN)
(OTCQX: MMNFF) just signed a $33 million
deal to acquire Kannaboost Technology Inc. and CSI Solutions
LLC, collectively known as Level Up, an Arizona-based vertically
integrated marijuana firm. OrganiGram (TSX.V: OGI) (OTCQX:
OGRMF) has just has signed a supply agreement with BC
Liquor Distribution Branch, the sole, wholesale distributor of
nonmedical cannabis for British Canada. And symbolic of its
presence in the cannabis market, Aphria (NYSE: APHA) (TSX:
APH) debuted on the New York Stock Exchange last week.
To view an infographic of this editorial, click here.
CBD Already Hot and Getting Hotter
No doubt about it, the CBD market is hot right now. With analyst
projections ranging from $2.1 billion to $3
billion within the next three to four years, historic change in
the form of a 2018 U.S. Farm Bill that could make CBD and
industrial hemp legal nationwide might send the market into
hyperdrive.
Diverse Approach Focused on Legal Market
Marijuana
Company of America Inc. (OTC: MCOA) has constructed a business
model around the immense potential of the industrial hemp-based CBD
market and just recently applied for an uplisting to the OTCQB in
conjunction with an S-1 filing and anticipated access to a $10
million line of equity financing. The company also tapped former
Price Waterhouse and Deloitte & Touche man Jesus Quintero for
its CFO job, where his extensive public company reporting and
SEC/SOX compliance experience should help expedite matters
handily.
The success of the company’s hempSMART line comes from its
innovative products, such as HempSMART Brain,
a unique formulation of Ayurvedic herbs and botanical compounds
with premium CBD designed to enhance brain function. The company’s
success also stems from its affiliate marketing program, which
allows people to earn income via commissions and bonuses, assisted
by a sophisticated networking architecture that was engineered to
maximize customer loyalty and market penetration.
Global Potential, Next Level Moves
MCOA has even tapped 35-year direct sales industry veteran Ian
Harvey to spearhead hempSMART’s upcoming international product
launch starting in Europe at the outset of 2019. As the company’s
global sales director, Harvey will seek to deliver the same kind of
success with the hempSMART network marketing program as was
demonstrated throughout his career in the direct sales
industry.
Recently the first of many regional events to be held across the
country took place, and the hempSMART South West Regional Event
showcases how quickly MCOA has built up its CBD product brand and
leveraged its advanced affiliate marketing platform to harness the
might of the $189.6 billion
direct sales industry. While the company is busy breaking new
ground at the forefront of direct sales and CBD, MCOA continues to
advance its property interests as well and is focused on leasing
turnkey facilities to sector operators in appropriate states and
jurisdictions. The latest news from the company’s CBD hemp farming
joint venture in New Brunswick, Canada, with Global Hemp Group Inc.
demonstrated the ingenuity of MCOA’s farming group. An OXBO bean
harvester was used at the New Brunswick project to maximize target
yields of the parts of the plant with the highest CBD
concentrations, despite unusually difficult crop conditions created
by this year’s drought.
Just the Beginning of the Property Leasing
Ladder
At the partnership’s Covered Bridge Acres joint venture in Scio,
Oregon, work is proceeding apace of expectations. The facility will
comprise when completed, some 19,000 square feet of greenhouses for
year-round production, paired up with traditional outdoor
orchard-style cultivation on the remaining square footage of the
109-acre site. MCOA plans to continue to expand its property
footprint in both the United States and Canada as the overall
cannabis industry heats up. The company may hold an ace up its
sleeve in the form of a close working relationship with British
Columbia-based Global Hemp Group. Both companies share a common
vision about the disruptive potential of industrial hemp,
particularly as evinced by the growing popularity
of CBD.
And while many in the mainstream media may still be skeptical
about what consumers seem to be discovering firsthand about
CBD’s health benefits, a growing body of
scientific data appears to back up popular sentiment. Research
regarding the ability of cannabinoids such as CBD to regulate
homeostasis by impacting the body’s endocannabinoid receptors found
throughout nearly every tissue system suggests that consumers are
not just experiencing some kind of placebo effect.
Two-Pronged Solution to Soaring Demand
MCOA has put together a noteworthy approach to the overall
space, emphasizing immediate access to legal areas of the market.
On one hand, Marijuana Company of America has a dynamic affiliate
marketing program to promote and sell its legal hemp-based consumer
products. In addition, the company has put together a growing
property-based presence that looks to increasingly benefit its
hempSMART brand’s performance metrics. CBD continues to be costly
to produce, and the demand for cultivation sites will likely
continue to increase proportionally.
A preeminent supplier and manufacturer of hemp-derived
phytocannabinoids, CV Sciences Inc. (OTCQB: CVSI)
added to its leading brand, PlusCBD
Oil™, with the release of its gummy product. CV Sciences
operates two distinct business segments: a drug development
division focused on developing and commercializing novel
therapeutics utilizing synthetic CBD, and a consumer product
division focused on manufacturing, marketing and selling
plant-based CBD products.
By acquiring control of Level Up, MedMen (CSE: MMEN)
(OTCQX: MMNFF) gains access to
two vertically integrated operations in Arizona, which include
retail locations in Scottsdale and Tempe, as well as 25,000 square
feet of cultivation and production capacity in Tempe and Phoenix,
and a stake in the top-selling K.I.N.D. Concentrates (“K.I.N.D.”)
brand, which is currently distributed in more than 90 percent of
Arizona dispensaries. The acquisition strengthens MedMen’s presence
in one of the top cannabis markets in the United States.
A leading licensed producer of cannabis for the medical and
adult-use recreational markets, OrganiGram (TSXV: OGI)
(OTCQX: OGRMF) has now secured cannabis distribution
agreements in eight of ten provinces in Canada. Organigram also
recently signed an agreement with to acquire 8,333 common shares of
Alpha-Cannabis Germany, representing a 25% stake in ACG’s capital.
ACG has been preparing the development and production of further
cannabis-based products for the swiftly growing German and European
markets.
In addition to uplisting on the NYSE, Aphria (NYSE:
APHA) (TSX: APH) recently closed acquisitions of assets in
Latin America and the Caribbean from Scythian Bioscences. As a
result of the transaction, Aphria has solidified an important
foothold in Latin America and the Caribbean by acquiring
industry-leading cannabis-related companies in Colombia, Argentina
and Jamaica as well as a right of first offer and refusal to a
majority interest in a Brazilian entity seeking a cannabis
cultivation and sales license.
CBD is quickly establishing itself as the darling of the booming
cannabis industry. Investors will want to keep a close eye on
companies such as MCOA that are able to operate within the
sizeable, already-legal portions of the overall cannabis market and
that have a specific emphasis on products containing CBD derived
from industrial hemp. However, the entire cannabinoid market is
worth examining in greater detail, while those companies with
unique advantages deserve special attention, as they could be
tomorrow’s brightest stars and richest buyouts.
For more information on Marijuana Company of America, visit
Marijuana
Company of America, Inc. (OTC: MCOA)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides
(1) access to our news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize
corporate news and information, (3) enhanced press release
services, (4) social media distribution and optimization services,
and (5) a full array of corporate communication solutions. As a
multifaceted financial news and content distribution company with
an extensive team of contributing journalists and writers, CNW is
uniquely positioned to best serve private and public companies that
desire to reach a wide audience of investors, consumers,
journalists and the general public. CNW has an ever-growing
distribution network of more than 5,000 key syndication outlets
across the country. By cutting through the overload of information
in today’s market, CNW brings its clients unparalleled visibility,
recognition and brand awareness. CNW is where news, content and
information converge.
Receive Text Alerts
from CannabisNewsWire: Text "Cannabis" to
21000
For more information please visit https://www.CannabisNewsWire.com and
or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the
CannabisNewsWire website applicable to all content provided by CNW,
wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by CNW are
solely those of CNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable CNW for any investment
decisions by their readers or subscribers. CNW is a news
dissemination and financial marketing solutions provider and is NOT
registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, CNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and CNW undertakes no
obligation to update such statements.
Source:
CannabisNewsWire
Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net